4
Changes in Ownership
Serina Therapeutics, Inc. Filed Acc 0001301120-25-000007
Chief Scientific Officer sold 4,326 shares at $5.20 ($22,495)
- Chief Scientific Officer acquired 4,326 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Moreadith Randall · Chief Scientific Officer
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2025-10-13 | Exercise or conversion : show line 1 in the form 10b5-1 | +4,326 | $0.06 | $260 | 4,326 | D |
| 2025-10-13 | Sale : show line 2 in the form 10b5-1 | −4,326 | $5.20 | $22,495 | 0 | D |
| Open-market sales · 4,326 sh · avg $5.20 · $22,495 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2025-10-13 | Exercise or conversion : show line 3 in the form 10b5-1 Stock Option (right to buy) | −4,326 | 417,186 | D |
Loading xslF345X05/wk-form4_1760462176.xml…